Evofem Biosciences Inc

NASDAQ:EVFM   3:59:49 PM EDT
0.48
+0.06 (+15.01%)
5:24:24 PM EDT: $0.46 -0.02 (-3.16%)
Other Pre-Announcement

Evofem Biosciences Announces Strong Q2 Results And Affirms 2022 Guidance

Published: 08/04/2022 21:04 GMT
(EVFM) - Evofem Biosciences Announces Strong Second Quarter 2022 Financial Results and Affirms 2022 Guidance.
Evofem Biosciences Inc - Continues to Expect Net Product Sales in Range of $30 to $35 Million for Its 2022 Fiscal Year.
Evofem Biosciences Inc - Remains on Track to Meet Its Goal of Reducing Costs by $50 Million in 2022.